CN104662149B - 制备重组人酪氨酸酶的方法 - Google Patents

制备重组人酪氨酸酶的方法 Download PDF

Info

Publication number
CN104662149B
CN104662149B CN201380039269.4A CN201380039269A CN104662149B CN 104662149 B CN104662149 B CN 104662149B CN 201380039269 A CN201380039269 A CN 201380039269A CN 104662149 B CN104662149 B CN 104662149B
Authority
CN
China
Prior art keywords
tyrosinase
human tyrosinase
human
gene
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380039269.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN104662149A (zh
Inventor
G.钱德拉莫里
S.马哈帕特拉
S.蒂马斯亚
D.H.丹德卡
S.克里斯兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever IP Holdings BV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Publication of CN104662149A publication Critical patent/CN104662149A/zh
Application granted granted Critical
Publication of CN104662149B publication Critical patent/CN104662149B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/18—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
    • C12Y114/18001—Tyrosinase (1.14.18.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201380039269.4A 2012-07-26 2013-07-10 制备重组人酪氨酸酶的方法 Expired - Fee Related CN104662149B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12177945.8 2012-07-26
EP12177945 2012-07-26
EP12184662.0 2012-09-17
EP12184662 2012-09-17
PCT/EP2013/064555 WO2014016118A1 (en) 2012-07-26 2013-07-10 A method of preparing recombinant human tyrosinase

Publications (2)

Publication Number Publication Date
CN104662149A CN104662149A (zh) 2015-05-27
CN104662149B true CN104662149B (zh) 2018-11-20

Family

ID=48793219

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380039269.4A Expired - Fee Related CN104662149B (zh) 2012-07-26 2013-07-10 制备重组人酪氨酸酶的方法

Country Status (7)

Country Link
US (2) US20150232818A1 (enExample)
EP (1) EP2877573B1 (enExample)
CN (1) CN104662149B (enExample)
AR (1) AR091904A1 (enExample)
EA (1) EA028538B1 (enExample)
IN (1) IN2015MN00102A (enExample)
WO (1) WO2014016118A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115025217B (zh) * 2022-05-13 2023-05-05 广东齐美医药生物科技集团有限公司 干细胞裂解物联合活性多糖以及酪氨酸酶抑制剂在制备药物或化妆品中的用途
CN117904149A (zh) * 2023-10-25 2024-04-19 中国医学科学院北京协和医院 一种表达酪氨酸酶的mRNA及用途
CN119837821B (zh) * 2023-12-13 2025-10-10 上海交通大学 一种用于治疗白癜风的基于酪氨酸酶的纳米透皮递送系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773291A (en) * 1989-04-26 1998-06-30 Sloan-Kettering Institute For Cancer Research Non-melanotytic mammalian cell constitutively expressing biologically active human tyrosinase and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515773A (en) * 1983-07-05 1985-05-07 Repligen Corporation Skin tanning composition and method
CA2054709A1 (en) * 1989-04-26 1990-10-27 Brigitte Bouchard Non-melanocytic, eucaryotic cell constitutively expressing biologically active human tyrosinase and use thereof
DE69429337T3 (de) * 1993-04-02 2012-08-30 Anticancer Inc. Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
EP2501374A4 (en) * 2009-11-13 2013-11-06 Warner Babcock Inst For Green Chemistry Llc COLORING COMPOSITION CONTAINING AROMATIC COMPOUND AND INITIATOR

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773291A (en) * 1989-04-26 1998-06-30 Sloan-Kettering Institute For Cancer Research Non-melanotytic mammalian cell constitutively expressing biologically active human tyrosinase and use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Copper treatment increases recombinant baculovirus production and polyhedrin and p10 expression;Lanier LM等;《Biotechniques》;19971031;第23卷(第4期);摘要，第734页最后1段-735页第1段，表1 *
Refinement of tools for targeted gene expression in Drosophila;Pfeiffer BD等;《Genetics》;20100809;第86卷(第2期);第736页第2栏最后1段，第738页第2栏第3段 *
The CUP1 promoter of Saccharomyces cerevisiae is inducible by copper in Pichia pastoris;Koller A等;《Yeast》;20000531;第16卷(第7期);摘要，表1 *

Also Published As

Publication number Publication date
EP2877573B1 (en) 2016-09-21
CN104662149A (zh) 2015-05-27
AR091904A1 (es) 2015-03-11
US20160324751A1 (en) 2016-11-10
US20150232818A1 (en) 2015-08-20
WO2014016118A1 (en) 2014-01-30
IN2015MN00102A (enExample) 2015-10-16
EA028538B1 (ru) 2017-11-30
EA201500174A1 (ru) 2015-06-30
EP2877573A1 (en) 2015-06-03

Similar Documents

Publication Publication Date Title
Forstova et al. Cooperation of structural proteins during late events in the life cycle of polyomavirus
Kahn et al. The major 85-kD surface antigen of the mammalian form of Trypanosoma cruzi is encoded by a large heterogeneous family of simultaneously expressed genes.
Hartmann et al. Baculovirus expression and characterization of catalytically active horseradish peroxidase
CN115698307A (zh) 断裂内含肽及其用途
CN104662149B (zh) 制备重组人酪氨酸酶的方法
Li et al. Expression of soluble recombinant transglutaminase from Zea mays in Pichia pastoris
NO322477B1 (no) P53 variant, nukleinsyre, ekspresjonskassett, vektor, farmasoytisk preparat samt anvendelse for fremstilling av et farmasoytisk preparat for behandling av hyperproliferative lidelse.
Basilion et al. Overexpression of iron-responsive element-binding protein and its analytical characterization as the RNA-binding form, devoid of an iron-sulfur cluster
CN101812127A (zh) 微管结合蛋白及其编码基因与应用
Balcueva et al. Human G protein γ11 and γ14 subtypes define a new functional subclass
WILSON et al. Cloning and characterization of hIF2, a human homologue of bacterial translation initiation factor 2, and its interaction with HIV-1 matrix
Spenger et al. Altering the surface properties of baculovirus Autographa californica NPV by insertional mutagenesis of the envelope protein gp64
McGLYNN et al. Large‐scale purification and characterisation of a recombinant epidermal growth‐factor receptor protein‐tyrosine kinase: Modulation of activity by multiple factors
JP2005519620A (ja) 遺伝子操作したバキュロウィルスおよびその使用
US6090621A (en) Signaling inositol polyphosphate 5-phosphatases (SIPs)
EA007273B1 (ru) Выделенный полипептид, связывающийся с каспазой -8, и способы его применения
CN114026228A (zh) 用于识别序列的工程化大范围核酸酶的优化
JP2006525032A (ja) Ｂａｃｅのグリコシル化変異体
Siow et al. Synapsin IIa: expression in insect cells, purification, and characterization
Xu et al. Translational inefficiency of acid β-glucosidase mRNA in transgenic mammalian cells
JP2003070475A (ja) シロアリ共生原生動物由来のセルラーゼ遺伝子
US6849438B1 (en) Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1)
BG63548B1 (bg) Полипептиди, съдържащи протеинови домени на gax, включени в транскрипцията и/или взаимнодействащи сдруги протеини, съответни нуклеинови киселини и тяхното използване
US6063592A (en) Kell protein proteolytic activity
KR100414182B1 (ko) 누에 배양세포로부터 분리한 프로테인 디설피드이소머레이즈를 코딩하는 ｃＤＮＡ 유전자의 염기서열 및그의 연역 아미노산

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210830

Address after: Rotterdam

Patentee after: Unilever Intellectual Property Holdings Ltd.

Address before: Rotterdam

Patentee before: Unilever Nederland B.V.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20181120